Featured Research

from universities, journals, and other organizations

Researchers Identify Essential Component Of Immunity Against The Hepatitis C Virus

Date:
October 27, 2003
Source:
Columbus Children's Hospital
Summary:
Researchers at Columbus Children’s Research Institute (CCRI) on the campus of Columbus Children’s Hospital have identified a key component of protective immunity against the hepatitis C virus, the major cause of chronic liver disease and transplantation in the United States.

Researchers at Columbus Children’s Research Institute (CCRI) on the campus of Columbus Children’s Hospital have identified a key component of protective immunity against the hepatitis C virus, the major cause of chronic liver disease and transplantation in the United States. The study found that successful control of hepatitis C infection required close cooperation between two types of white blood cells know as CD4+ “helper” and CD8+ “killer” T lymphocytes. The findings, published in the October 24 issue of Science, indicate that the immune system is unable to eliminate the virus without the CD4+ T lymphocytes.

“Our goal is to understand how a person’s immune response determines the outcome of the hepatitis C infection,” said Christopher M. Walker, Ph.D., director of the Center for Vaccines and Immunity at CCRI on the campus of Columbus Children's Hospital and professor of pediatrics at The Ohio State University College of Medicine and Public Health. “Approximately 70 percent of individuals exposed to hepatitis C become lifelong carriers of the virus. The remaining individuals successfully contain the infection and appear to have long-lasting immunity to the virus. Our finding that CD4+ T helper cells are essential for this protection move us one step closer to developing an effective vaccine for hepatitis C,” he added.

There are 170 million people around the world (including 4 million in the United States) infected with the hepatitis C virus. Most of these people don’t know they are chronic carriers of the virus until they develop liver problems.

The study, conducted in an animal model of human hepatitis C infection, demonstrated that temporary depletion of the CD4+ T helper cells abolished protective immunity against a second infection with the virus. The CD8+ T killer lymphocytes alone were an ineffective defense as the virus rapidly mutated to evade this immune response.

“Vaccines are the most cost-effective way to contain viruses like hepatitis C and with these findings, we move one step closer to that goal,” added Dr. Walker.


Story Source:

The above story is based on materials provided by Columbus Children's Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Columbus Children's Hospital. "Researchers Identify Essential Component Of Immunity Against The Hepatitis C Virus." ScienceDaily. ScienceDaily, 27 October 2003. <www.sciencedaily.com/releases/2003/10/031027064057.htm>.
Columbus Children's Hospital. (2003, October 27). Researchers Identify Essential Component Of Immunity Against The Hepatitis C Virus. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2003/10/031027064057.htm
Columbus Children's Hospital. "Researchers Identify Essential Component Of Immunity Against The Hepatitis C Virus." ScienceDaily. www.sciencedaily.com/releases/2003/10/031027064057.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins